Experimental drug shows early promise against inherited form of ALS, trial indicates

ScienceDaily
Jul 8, 2020, 5:43 pm142 pts
A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Largest turtle nest in the world revealed in drone study 172

Experimental ocean climate fixes move ahead without regulation 125

$200 Million For Renewables-Friendly Flywheel Energy Storage 123

Study warns US emissions progress may flatline 117

Red Sea Deals, Mast’s Burial Credits and Netflix Forest Bets 114

Bluetti’s new Apex 300 station + bundles get up to $2,377 in exclusive savings, Lectric Endless Summer e-bike Sale, Aiper, more 111

Invasive Plants are Rapidly Changing the Tropics 105

BYD insists its rapid EV growth can’t be stopped, even without electric car grants 105

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.